Hanan M. A. El Henafy

Dr. Hanan M. A. El Henafy


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Toxics
Verified
Journal Article
Open access
PDF file
Heba Muhammed KhalilHeba Muhammed Khalil
Heba Muhammed Khalil
HHHanan Mohammed El Henafy
Hanan Mohammed El Henafy
IKIslam A Khalil
Islam A Khalil
ABAlaa F. Bakr
Alaa F. Bakr
MFMohamed Ibrahim Fahmy
Mohamed Ibrahim Fahmy
RERiham A. El-Shiekh
Riham A. El-Shiekh
Cisplatin (Cis) is a potent chemotherapeutic agent; however, it is linked with oxidative stress, inflammation, and apoptosis, which may harmfully affect the brain. Hypericum perforatum L. (HP L.) is a strong medicinal plant, but its hydrophobic polyphenolic compounds limit its activity. Therefore, our study aimed to investigate the neuroprotective action of HP L. and its nanoemulsion (NE) against Cis-induced neurotoxicity. The prepared HP.NE was subjected to characterization. The droplet size distribution, surface charge, and morphology were evaluated. In addition, an in vitro dissolution study was conducted. Compared to Cis-intoxicated rats, HP L. and HP.NE-treated rats displayed improved motor activity and spatial working memory. They also showed an increase in their antioxidant defense system and a reduction in the levels of pro-inflammatory cytokines in the brain. Moreover, they showed an increase in the expression levels of the PON-3 and GPX genes, which are associated with a reduction in the brain levels of COX-2 and TP-53. These findings were confirmed by reducing the immunohistochemical expression of nuclear factor kappa (NF-ƘB) and enhanced Ki-67 levels. In conclusion, HP L. is a promising herb and could be used as an adjuvant candidate to ameliorate chemotherapeutic-induced neurotoxicity. Moreover, HP.NE has superior activity in lessening Cis-induced oxidative stress, inflammation, and apoptosis in brain tissue.

2 September 2025 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
NANorah Saeed Al-Zahrani
Norah Saeed Al-Zahrani
HZHind Zafrah
Hind Zafrah
AHAlshehri Hanan Hassan
Alshehri Hanan Hassan
ENEman Mohamad El nashar
Eman Mohamad El nashar
HHHanan Mohammed El Henafy
Hanan Mohammed El Henafy

16 December 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Heba Muhammed KhalilHeba Muhammed Khalil
Heba Muhammed Khalil
WEWalaa A. M. Eid
Walaa A. M. Eid
MEMohammed Helmi ElNabalway
Mohammed Helmi ElNabalway
ENEman Mohamad El nashar
Eman Mohamad El nashar
JAJaber Saad Al-Tarish
Jaber Saad Al-Tarish
HHHanan Mohammed El Henafy
Hanan Mohammed El Henafy
Date (Phoenix dactylifera L.) seeds (PDL) have recently evoked significant attention for their therapeutic potential against numerous diseases. Aflatoxin B1 (AFB1) is an inevitable environmental hazard that pollutes foods and may harm the heart. This study investigated the beneficial effect of PDL against cardiac toxicity induced by AFB1 in male offspring. Female albino rats received PDL (200 mg/kg) orally for 14 days before mating till weaning and AFB1 (50 μg/kg) intramuscularly throughout gestation and lactation. At postnatal day 60, male offspring hearts were collected. Compared to AFB1 intoxicated group, PDL-treated offspring displayed improved cardiac biomarkers, an increase in their antioxidant defense, and a decrease in the cardiac proinflammatory cytokines. Additionally, a reduction in the expression levels of Bcl2 and Nrf2 was observed, with genes linked to increased cardiac caspase-3, Bax, ACE1, P53, and cytochrome C levels. In conclusion, PDL acts as a potential adjuvant agent for ameliorating cardiac toxicity and apoptosis resulting from exposure to AFB1. This is attributed to its antioxidative and anti-inflammatory effects, as well as its capacity to sequester free radicals within cardiac tissue.

11 March 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
HHHanan Mohammed El Henafy
Hanan Mohammed El Henafy
Mansour A. AlghamdiMansour A. Alghamdi
Mansour A. Alghamdi
HZHind Zafrah
Hind Zafrah
NANorah Saeed Al-Zahrani
Norah Saeed Al-Zahrani
ENEman Mohamad El nashar
Eman Mohamad El nashar

17 November 2025 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
AHAlshehri Hanan Hassan
Alshehri Hanan Hassan
ENEman Mohamad El nashar
Eman Mohamad El nashar
NANorah Saeed Al-Zahrani
Norah Saeed Al-Zahrani
HZHind Zafrah
Hind Zafrah
HHHanan Mohammed El Henafy
Hanan Mohammed El Henafy